Top

Gepubliceerd in:

12-04-2017

Psychometric validation of the dysmenorrhea daily diary (DysDD): a patient-reported outcome for dysmenorrhea

Auteurs: Allison M. Nguyen, Rob Arbuckle, Tjeerd Korver, Fang Chen, Beverley Taylor, Alice Turnbull, Josephine M. Norquist

Gepubliceerd in: Quality of Life Research | Uitgave 8/2017

Abstract

Purpose

The objective of this study was to evaluate the psychometric properties of the Dysmenorrhea Daily Diary (DysDD), an electronic patient-reported outcome, in a sample of 355 women with primary dysmenorrhea enrolled in a phase IIb, multicenter, randomized, partially blinded, placebo-controlled trial for treatment of dysmenorrhea.

Methods

Subjects completed the DysDD over three menstrual cycles, one pre-treatment baseline cycle and two treatment cycles. The DysDD was administered alongside the Menstrual Distress Questionnaire (MDQ), the Short-Form 36 Version 2.0 (SF-36v2), and a Global Assessment of Change (GAC). Item response distributions, test–retest reliability, concurrent and known groups validity, responsiveness, and minimally important difference (MID) were evaluated for the DysDD.

Results

As expected, item response distributions varied throughout the menstrual period for all items, with the response scales fully utilized. Within-cycle test–retest reliability was adequate (weighted kappa: 0.5–0.7), although between-cycle test–retest was poor (weighted kappa: 0.1–0.5), most likely due to the highly variable nature of dysmenorrhea between cycles rather than limitations of the measure. Correlations with the MDQ and SF-36v2 were low-moderate, but in the predicted direction, supporting concurrent validity. There were significant differences in DysDD scores across severity groups based on pain medication use. The DysDD was responsive to changes in patients’ dysmenorrhea with significantly different changes in scores between change groups (p < 0.0001). MID analyses suggest changes on the DysDD 0–10 pelvic pain score of three points can be considered clinically meaningful.

Conclusions

Overall, findings indicate that the DysDD has acceptable reliability and is a valid and responsive instrument for assessing dysmenorrhea.

vorige artikel Development and refinement of the WAItE: a new obesity-specific quality of life measure for adolescents

volgende artikel Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes

Proctor, M., & Farquhar, C. (2006). Diagnosis and management of dysmenorrhoea. BMJ, 332(7550), 1134–1138. doi:10.1136/bmj.332.7550.1134.CrossRefPubMedPubMedCentral

Ali, Z., Burnett, I., Eccles, R., North, M., Jawad, M., Jawad, S., et al. (2007). Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea. Current Medical Research and Opinion, 23(4), 841–851. doi:10.1185/030079907X182239.CrossRefPubMed

Harel, Z. (2006). Dysmenorrhea in adolescents and young adults: Etiology and management. Journal of Pediatric and Adolescent Gynecology, 19(6), 363–371.CrossRefPubMed

Harel, Z. (2002). A contemporary approach to dysmenorrhea in adolescents. Paediatric Drugs, 4(12), 797–805.CrossRefPubMed

Coco, A. S. (1999). Primary dysmenorrhea. American Family Physician, 60(2), 489–496.PubMed

Eby, G. A. (2007). Zinc treatment prevents dysmenorrhea. Medical Hypotheses, 69(2), 297–301. doi:10.1016/j.mehy.2006.12.009.CrossRefPubMed

Santer, M., Wyke, S., & Warner, P. (2007). What aspects of periods are most bothersome for women reporting heavy menstrual bleeding? Community survey and qualitative study. BMC Women’s Health, 7, 8. doi:10.1186/1472-6874-7-8.CrossRefPubMedPubMedCentral

Unsal, A., Ayranci, U., Tozun, M., Arslan, G., & Calik, E. (2010). Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students. Upsala Journal of Medical Sciences, 115(2), 138–145. doi:10.3109/03009730903457218.CrossRefPubMedPubMedCentral

Food and Drug Administration (FDA) (2009). Guidance for industry: Patient-reported outcome measures—use in medical product development to support labeling claims. http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.

10.

European Medicines Agency (2005). Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evalutation of medicinal products. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf.

11.

Chesney, M. A., & Tasto, D. L. (1975). The development of the menstrual symptom questionnaire. Behavioural Research and Theory, 13(4), 237–244.CrossRef

12.

Moos, R. H. (1968). The development of a menstrual distress questionnaire. Psychosomatic Medicine, 30(6), 853.CrossRefPubMed

13.

Andersch, B., & Milsom, I. (1982). An epidemiologic study of young women with dysmenorrhea. American Journal of Obstetrics and Gynecology, 144(6), 655–660.CrossRefPubMed

14.

Melzack, R. (1975). The McGill Pain Questionnaire: Major properties and scoring methods. Pain, 1(3), 277–299.CrossRefPubMed

15.

Melzack, R. (1987). The short-form McGill pain questionnaire. Pain, 30(2), 191–197.CrossRefPubMed

16.

Biberoglu, K. O., & Behrman, S. J. (1981). Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness. American Journal of Obstetrics and Gynecology, 139, 645–654.CrossRefPubMed

17.

Nguyen, A. M., Humphrey, L., Kitchen, H., Rehman, T., & Norquist, J. M. (2014). A qualitative study to develop a patient-reported outcome for dysmenorrhea. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. doi:10.1007/s11136-014-0755-z.

18.

Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., et al. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value in Health, 8(2), 94–104.CrossRefPubMed

19.

Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-ltem short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30, 473–483.CrossRefPubMed

20.

Nunnally, J. C., Bernstein, I. H. (1994). Psychometric theory. New York: McGraw-Hill.

21.

Sloan, J., Symonds, T., Vargas-Chanes, D., & Fridley, B. (2003). Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials. Drug Information Journal, 37(1), 23–31.CrossRef

22.

Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.CrossRefPubMed

23.

Turk, D. C., Dworkin, R. H., Burke, L. B., Gershon, R., Rothman, M., Scott, J., et al. (2006). Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain, 125(3), 208–215.CrossRefPubMed

24.

Habiba, M., Julian, S., Taub, N., Clark, M., Rashid, A., Baker, R., et al. (2010). Limited role of multi-attribute utility scale and SF-36 in predicting management outcome of heavy menstrual bleeding. European Journal of Obstetrics and Gynecology and Reproductive Biology, 148(1), 81–85.CrossRefPubMed

25.

Dworkin, R. H., Turk, D. C., McDermott, M. P., Peirce-Sandner, S., Burke, L. B., Cowan, P., et al. (2009). Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain, 146(3), 238–244.CrossRefPubMed

Titel: Psychometric validation of the dysmenorrhea daily diary (DysDD): a patient-reported outcome for dysmenorrhea
Auteurs: Allison M. Nguyen
Rob Arbuckle
Tjeerd Korver
Fang Chen
Beverley Taylor
Alice Turnbull
Josephine M. Norquist
Publicatiedatum: 12-04-2017
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 8/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-017-1562-0

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 8/2017

Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes

A systematic review of measurement properties of patient-reported outcome measures for use in patients with foot or ankle diseases

Health-related quality of life in patients receiving long-term opioid therapy: a systematic review with meta-analysis

Predictors of the course of quality of life during therapy in women with primary breast cancer

Changes in quality of life after elective surgery: an observational study comparing two measures

Erratum to: Symptom burden and life challenges reported by adult chordoma patients and their caregivers